0001209191-20-030494.txt : 20200519 0001209191-20-030494.hdr.sgml : 20200519 20200519163313 ACCESSION NUMBER: 0001209191-20-030494 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200515 FILED AS OF DATE: 20200519 DATE AS OF CHANGE: 20200519 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Tatsis Ourania CENTRAL INDEX KEY: 0001789815 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 20894135 MAIL ADDRESS: STREET 1: C/O VERTEX PHARMACEUTICALS, INC. STREET 2: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-05-15 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001789815 Tatsis Ourania C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 0 1 0 0 EVP, Chief Regulatory Officer Common Stock 2020-05-15 4 S 0 10 276.35 D 12848 D Common Stock 2020-05-15 4 S 0 17 279.93 D 12831 D Common Stock 2020-05-15 4 S 0 21 281.23 D 12810 D Common Stock 2020-05-15 4 S 0 10 284.30 D 12800 D Common Stock 2020-05-15 4 S 0 20 286.12 D 12780 D Common Stock 2020-05-15 4 S 0 33 287.61 D 12747 D Common Stock 2020-05-15 4 S 0 9 288.38 D 12738 D Transaction made pursuant to Ms. Tatsis' company-approved trading plan under Rule 10b5-1. Open market sales reported on this line occurred at a weighted average price of $279.93 (range $279.68 to $280.53). Ms. Tatsis undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Open market sales reported on this line occurred at a weighted average price of $281.23 (range $280.73 to $281.62). Open market sales reported on this line occurred at a weighted average price of $286.12 (range $285.79 to $286.44). Open market sales reported on this line occurred at a weighted average price of $287.61 (range $287.04 to $287.99). Open market sales reported on this line occurred at a weighted average price of $288.38 (range $288.20 to $288.47). /s/ Sabrina Yohai, Attorney-in-Fact 2020-05-19